QUAZEPAM
| Brand name | DORAL |
|---|---|
| Active ingredient | QUAZEPAM |
| Strength | 7.5MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 1987 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7608616 | June 2028 | use U-1012 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.